A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study.
Identificadores
Identificadores
Fecha de publicación
2014Título de revista
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Tipo de contenido
Artigo